Lee & Man Paper Manufacturing Ltd (2314)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 3.140 |
|---|---|
| 52-week range | 2.660 – 4.545 |
| Return, 1 month / 3 months | −8.3% / −20.0% |
| Return, 1 year / 3 years | +14.8% / +64.3% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 36.5% |
| Worst drawdown (1 year) | -29.1% |
| Average daily value traded | 16.72M HKD |
| Dividend yield | 6.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lee & Man Paper Manufacturing makes paper and pulp products, based in Hong Kong with production operations across Asia. The company produces containerboard and other packaging papers used to make corrugated boxes, serving packaging converters and industrial customers. It also makes tissue paper for consumer and household use. Its mills turn wood pulp and recovered paper into the rolls and sheets that its customers convert into packaging and everyday paper products.
Lee & Man Paper Manufacturing Ltd trades under the code 2314 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lee & Man Paper Manufacturing Ltd (2314) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 3.140 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 403 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.8% and over the last three months it fell 20.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.1% | ||
| From 52-week high | -29.0% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 25.3% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.1% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 16.72M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | −8.3% |
| 3 months | −20.0% |
| 6 months | −0.0% |
| 1 year | +14.8% |
| 3 years | +64.3% |
| 5 years | −33.7% |
Signals
| 50-day / 200-day average | 3.548 / 3.382 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.091 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | HKD 0.1120 |
| 4 May 2026 | HKD 0.0930 |
| 19 Aug 2025 | HKD 0.0660 |
| 12 May 2025 | HKD 0.0450 |
| 14 Aug 2024 | HKD 0.0620 |
| 13 May 2024 | HKD 0.0610 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.